D. Burton, R. Desrosiers, R. Doms, W. Koff, P. Kwong et al., HIV vaccine design and the neutralizing antibody problem, Nature Immunology, vol.74, issue.3, pp.233-236, 2004.
DOI : 10.1038/ni0304-233

B. Haynes and D. Montefiori, Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates, Expert Review of Vaccines, vol.5, issue.3, pp.347-363, 2006.
DOI : 10.1586/14760584.5.3.347

D. Richman, T. Wrin, S. Little, and C. Petropoulos, Rapid evolution of the neutralizing antibody response to HIV type 1 infection, Proceedings of the National Academy of Sciences, vol.100, issue.7, pp.4144-4149, 2003.
DOI : 10.1073/pnas.0630530100

K. Skrabal, S. Saragosti, J. Labernardiere, F. Barin, F. Clavel et al., Human Immunodeficiency Virus Type 1 Variants Isolated from Single Plasma Samples Display a Wide Spectrum of Neutralization Sensitivity, Journal of Virology, vol.79, issue.18, pp.11848-11857, 2005.
DOI : 10.1128/JVI.79.18.11848-11857.2005

X. Wei, J. Decker, S. Wang, H. Hui, J. Kappes et al., Antibody neutralization and escape by HIV-1, Nature, vol.422, issue.6929, pp.307-312, 2003.
DOI : 10.1038/nature01470

P. Gilbert, M. Ackers, P. Berman, D. Francis, V. Popovic et al., HIV???1 Virologic and Immunologic Progression and Initiation of Antiretroviral Therapy among HIV???1???Infected Subjects in a Trial of the Efficacy of Recombinant Glycoprotein 120 Vaccine, The Journal of Infectious Diseases, vol.192, issue.6, pp.974-983, 2005.
DOI : 10.1086/432734

J. Mascola, Defining the Protective Antibody Response for HIV-1, Current Molecular Medicine, vol.3, issue.3, pp.209-216, 2003.
DOI : 10.2174/1566524033479799

A. Trkola, H. Kuster, P. Rusert, B. Joos, M. Fischer et al., Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies, Nature Medicine, vol.14, issue.6, pp.615-622, 2005.
DOI : 10.1016/j.virol.2004.05.022

Y. Cao, L. Qin, L. Zhang, J. Safrit, and D. Ho, Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection, New England Journal of Medicine, vol.332, issue.4, pp.201-208, 1995.
DOI : 10.1056/NEJM199501263320401

P. Carotenuto, D. Looij, L. Keldermans, F. De-wolf, and J. Goudsmit, Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection, AIDS, vol.12, issue.13, pp.1591-1600, 1988.
DOI : 10.1097/00002030-199813000-00005

D. Montefiori, G. Pantaleo, L. Fink, J. Zhou, J. Zhou et al., Neutralizing and Infection-Enhancing Antibody Responses to Human Immunodeficiency Virus Type 1 in Long-Term Nonprogressors, Journal of Infectious Diseases, vol.173, issue.1, pp.60-67, 1996.
DOI : 10.1093/infdis/173.1.60

A. Pilgrim, G. Pantaleo, O. Cohen, L. Fink, J. Zhou et al., Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long???Term???Nonprogressive Infection, The Journal of Infectious Diseases, vol.176, issue.4, pp.924-932, 1997.
DOI : 10.1086/516508

Y. Zhang, C. Fracasso, J. Fiore, A. Bjorndal, G. Angarano et al., Augmented Serum Neutralizing Activity against Primary Human Immunodeficiency Virus Type 1 (HIV???1) Isolates in Two Groups of HIV???1???Infected Long???Term Nonprogressors, The Journal of Infectious Diseases, vol.176, issue.5, pp.1180-1187, 1997.
DOI : 10.1086/514111

V. Martinez, D. Costagliola, O. Bonduelle, N. , N. Schnuriger et al., Combination of HIV???1???Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long???Term Nonprogression, The Journal of Infectious Diseases, vol.191, issue.12, pp.2053-2063, 2005.
DOI : 10.1086/430320

S. Deeks and B. Walker, Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007.
DOI : 10.1016/j.immuni.2007.08.010

A. Saez-cirion, G. Pancino, M. Sinet, A. Venet, and O. Lambotte, HIV controllers: how do they tame the virus?, Trends in Immunology, vol.28, issue.12, pp.532-540, 2007.
DOI : 10.1016/j.it.2007.09.002

S. Migueles, M. Sabbaghian, W. Shupert, M. Bettinotti, F. Marincola et al., HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proceedings of the National Academy of Sciences, vol.97, issue.6, pp.2709-2714, 2000.
DOI : 10.1073/pnas.050567397

M. Betts, M. Nason, S. West, D. Rosa, S. Migueles et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006.
DOI : 10.1182/blood-2005-12-4818

S. Migueles, A. Laborico, W. Shupert, M. Sabbaghian, R. Rabin et al., HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002.
DOI : 10.1038/ni845

A. Saez-cirion, C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia et al., HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.104, issue.16, pp.6776-6781, 2007.
DOI : 10.1073/pnas.0611244104

URL : https://hal.archives-ouvertes.fr/pasteur-00142658

S. Potter, C. Lacabaratz, O. Lambotte, S. Perez-patrigeon, B. Vingert et al., Preserved Central Memory and Activated Effector Memory CD4+ T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study, Journal of Virology, vol.81, issue.24, pp.13904-13915, 2007.
DOI : 10.1128/JVI.01401-07

URL : https://hal.archives-ouvertes.fr/pasteur-00193768

T. Harrer, E. Harrer, S. Kalams, T. Elbeik, S. Staprans et al., Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection, AIDS Research and Human Retroviruses, vol.12, issue.7, pp.585-592, 1996.
DOI : 10.1089/aid.1996.12.585

J. Bailey, K. Lassen, H. Yang, T. Quinn, S. Ray et al., Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy, Journal of Virology, vol.80, issue.10, pp.4758-4770, 2006.
DOI : 10.1128/JVI.80.10.4758-4770.2006

F. Pereyra, M. Addo, D. Kaufmann, Y. Liu, T. Miura et al., Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.4, pp.563-571, 2008.
DOI : 10.1086/526786

A. Hessell, L. Hangartner, M. Hunter, C. Havenith, F. Beurskens et al., Fc receptor but not complement binding is important in antibody protection against HIV, Nature, vol.75, issue.7158, pp.101-104, 2007.
DOI : 10.1038/nature06106

V. Holl, M. Peressin, S. Schmidt, T. Decoville, S. Zolla-pazner et al., Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation, Blood, vol.107, issue.11, pp.4466-4474, 2006.
DOI : 10.1182/blood-2005-08-3490

V. Gó-mez-román, L. Patterson, D. Venzon, D. Liewehr, K. Aldrich et al., Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIVmac251, The Journal of Immunology, vol.174, issue.4, pp.2185-2189, 2005.
DOI : 10.4049/jimmunol.174.4.2185

O. Lambotte, F. Boufassa, Y. Madec, A. Nguyen, C. Goujard et al., HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005.
DOI : 10.1086/433188

G. Tomaras, N. Yates, P. Liu, L. Qin, G. Fouda et al., Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia, Journal of Virology, vol.82, issue.24, pp.12449-12463, 2008.
DOI : 10.1128/JVI.01708-08

B. Wang, W. Liu, S. Kang, M. Alam, C. Huang et al., Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles, Journal of Virology, vol.81, issue.20, pp.10869-10878, 2007.
DOI : 10.1128/JVI.00542-07

B. Haynes, J. Fleming, S. Clair, E. Katinger, H. Stiegler et al., Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies, Science, vol.308, issue.5730, pp.1906-1908, 2005.
DOI : 10.1126/science.1111781

A. Alfsen and M. Bomsel, HIV-1 gp41 Envelope Residues 650-685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide, Journal of Biological Chemistry, vol.277, issue.28, pp.25649-25659, 2002.
DOI : 10.1074/jbc.M200554200

J. Mascola, D. Souza, P. Gilbert, P. Hahn, B. Haigwood et al., Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines, Journal of Virology, vol.79, issue.16, pp.10103-10107, 2005.
DOI : 10.1128/JVI.79.16.10103-10107.2005

M. Li, F. Gao, J. Mascola, L. Stamatatos, V. Polonis et al., Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies, Journal of Virology, vol.79, issue.16, pp.10108-10125, 2005.
DOI : 10.1128/JVI.79.16.10108-10125.2005

J. Mascola, M. Louder, C. Winter, R. Prabhakara, D. Rosa et al., Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells, Journal of Virology, vol.76, issue.10, pp.4810-4821, 2002.
DOI : 10.1128/JVI.76.10.4810-4821.2002

P. Goepfert, G. Tomaras, H. Horton, D. Montefiori, G. Ferrari et al., Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers, Vaccine, vol.25, issue.3, pp.510-518, 2007.
DOI : 10.1016/j.vaccine.2006.07.050

C. Lacabaratz-porret, A. Urrutia, J. Doisne, C. Goujard, C. Deveau et al., Impact of Antiretroviral Therapy and Changes in Virus Load on Human Immunodeficiency Virus (HIV)???Specific T Cell Responses in Primary HIV Infection, The Journal of Infectious Diseases, vol.187, issue.5, pp.748-757, 2003.
DOI : 10.1086/368333

B. Emu, E. Sinclair, H. Hatano, A. Ferre, B. Shacklett et al., HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control, Journal of Virology, vol.82, issue.11, pp.5398-5407, 2008.
DOI : 10.1128/JVI.02176-07

J. Binley, E. Lybarger, E. Crooks, M. Seaman, E. Gray et al., Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C, Journal of Virology, vol.82, issue.23, pp.11651-11668, 2008.
DOI : 10.1128/JVI.01762-08

B. Keele, L. Tazi, S. Gartner, Y. Liu, T. Burgon et al., Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.82, issue.11, pp.5548-5561, 2008.
DOI : 10.1128/JVI.00124-08